Studies of aminorex, a new anorexigenic agent.
D000328:Adult; D000368:Aged; D001066:Appetite / Q000187:drug effects; D001067:Appetite Depressants / Q000009:adverse effects / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D002319:Cardiovascular System / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D003913:Dextroamphetamine / Q000009:adverse effects / Q000627:therapeutic use; D004053:Diethylpropion / Q000009:adverse effects / Q000627:therapeutic use; D004064:Digestive System / Q000187:drug effects; D005260:Female; D006029:Glycosuria / Q000139:chemically induced; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D007964:Leukocytosis / Q000139:chemically induced; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*; D010080:Oxazoles / Q000009:adverse effects / Q000627:therapeutic use*; D010633:Phenmetrazine / Q000009:adverse effects / Q000627:therapeutic use; D010919:Placebos; D011507:Proteinuria / Q000139:chemically induced; D011776:Pyuria / Q000139:chemically induced; D012871:Skin Diseases / Q000139:chemically induced; D014554:Urination / Q000187:drug effects
D001067:Appetite Depressants; D010080:Oxazoles; D010919:Placebos; D001219:Aspartate Aminotransferases; D004053:Diethylpropion; D003913:Dextroamphetamine; D010633:Phenmetrazine